Alec J Redwood

Alec J Redwood
University of Western Australia | UWA · Institute for Respiratory Health

PhD

About

69
Publications
10,472
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
1,186
Citations
Introduction
Associate Professor Redwood works at the Univeristy of Western Australia. He is a Principle Research Fellow working on neoantigen vaccines for cancer immunotherapy. Dr Redwood is also the head of the Vaccines and Viral Immunity Group which focuses on cytomegaolovirus (CMV) immune evasion and genetics. A particular focus of this group is the use of CMV as a vaccine vector for multiple infectious agents and as a vector for cancer immunotherapy.
Additional affiliations
July 2018 - present
University of Western Australia
Position
  • Fellow
August 2014 - June 2018
Murdoch University
Position
  • Professor (Associate)
January 2001 - present
University of Western Australia
Position
  • Professor (Assistant)

Questions

Question (1)
Question
Does anyone know of an immortalised BALB/c derived, dendritic cell line that is well characterised? I can only find B57 derived lines.

Projects

Projects (3)
Project
-Drug Hypersensitivity is a "Type B" Adverse Drug Reaction (ADR) which has high global morbidity and mortality, and are immunologically-mediated. -Different drugs can have different mechanisms in which they initiate a hypersensitivity reaction (Hapten, pi model and/or altered peptide model). -Gaining a better understanding of the immunological requirements needed for ADR to occur will aid in understanding the relevant mechanisms, and help clinically for treatments which have known risk factors (ie. HLA alleles) with low positive predictive values.